Twitter Logo Youtube Circle Icon LinkedIn Icon

France > Intellectual property > Patents > Law firm and leading lawyer rankings


Index of tables

  1. Intellectual property: patents
  2. Other recommended firms
  3. Leading individuals
  4. Next generation lawyers

Next generation lawyers

  1. 1

Who Represents Who

Find out which law firms are representing which Patents clients in France using The Legal 500's new comprehensive database of law firm/client relationships. Instantly search over 925,000 relationships, including over 83,000 Fortune 500, 46,000 FTSE350 and 13,000 DAX 30 relationships globally. Access is free for in-house lawyers, and by subscription for law firms. For more information, contact


Allen & Overy LLP is ‘top of the game’ and provides ‘a very high level of service’. The firm has ‘deep IP and pharmaceuticals industry knowledge’, handling many ground-breaking cases in the sector. It is involved in a major case regarding the validity of a second medical use patent and successfully represented Merck Sharp & Dohme in one of the first cases in France involving antibodies. Novartis is a client. Electronics is another field of prominent expertise. Other work includes assisting Google in a patent case involving Google play apps and acting for Archos in a pan-European case brought by Philips regarding essential patents. Practice head Laëtitia Bénard is ‘very impressive and the must-use lawyer in the life sciences area’. The ‘very thoughtful’ David Por has ‘good analytical and communicative skills’.

The ‘excellentBird & Bird is involved in high-profile global and domestic patent cases in several sectors, although the firm is particularly strong in healthcare, food, IT and electronics. The full-service IP team attracted many new clients in 2016 and also obtained great results in several cases. The practice is defending Nestlé in an infringement action initiated by Nutricia regarding patents on nutritional supplements. It is also representing Edwards Life Sciences in a European patent infringement case concerning endovascular heart valves initiated by Boston Scientific. Accord Healthcare, Actavis and Canon are also clients. Practice head Yves Bizollon has ‘high expertise’ and is ‘easy to talk with’. The other key figure is Anne-Charlotte Le Bihan.

Gide Loyrette Nouel A.A.R.P.I.knows how to best defend its clients’ interests’. The ‘high-level’ team is involved in domestic and multi-jurisdictional patent proceedings in electronics, mechanical products and pharmaceuticals. In one matter, it is representing Ono Pharmaceuticals and Bristol-Myers Squibb in the French aspects of a patent dispute relating to a revolutionary immuno-oncology treatment. It also obtained the withdrawal of all claims against its client Nokia (NSN) by patent troll High Point. The full-service team includes the ‘excellent litigatorsGrégoire Triet, Arnaud Michel, Emmanuel Larere and Raphaëlle Dequiré-Portier. Jean-Hyacinthe de Mitry was promoted to partner.

European boutique Hoyng Rokh Monegier is ‘excellent, responsive and makes deadlines’. It ‘provides an excellent level of service and its knowledge of the legal cases and applicable law is outstanding’. The firm is handling many high-profile and landmark cases in the healthcare and telecoms sectors for key players. It is representing Core Wireless Licensing before the Court of Appeal of Paris regarding essential patent rights enforcement (FRAND) against LG Electronics, as well as acting for Merck Sharp & Dohme Animal Health and Intervet International in patent infringement proceedings against Bayer regarding the manufacturing of a medicinal dog collar. AstraZeneca, Sanofi and Lundbeck are also clients. Practice head Denis Monégier du Sorbier is highly recommended, as are the ‘really outstandingBenoît Strowel and Sophie Micallef, who is ‘very good in both patent and trade mark matters’.

Cabinet Schertenleib is ‘a leading firm in the pharmaceutical sector with particular expertise in biotech cases’. The three-lawyer boutique handles highly strategic cases, often defending new entrants facing proceedings from leading laboratories regarding blockbuster drugs. It is notably acting for Mylan in a series of cases and is representing Sandoz in the Pregabalin case. The practice also handles antibodies litigation and is acting in other industrial fields. Eli Lilly and Teva are also clients. Denis Schertenleib has ‘a good technical background, is very experienced and a tenacious litigator’. Counsels Ombeline Degrèze-Péchade and Matthieu Dhenne are also names to note.

Specialist patent firm Véron & Associésexcels in its field’. ‘Lawyers work in close collaboration with their clients, especially in an international context’. The practice handles cases in various sectors, including healthcare, electronics, chemicals, telecoms and mechanical engineering. The firm, which manages many strategic cases, was recently involved in a landmark bio-similar dispute and represented Vringo in a FRAND litigation. Airbus Helicopters, AstraZeneca, Honeywell and Lilly are clients. The team notably includes Sabine Agé, Amandine Métier and of counsel Pierre Véron. Thomas Bouvet joined Jones Day. Since publication Isabelle Romet has left the firm.

Amar Goussu Staub, formerly Lavoix Avocats, is involved in a number of landmark FRAND litigation and arbitration cases. Cyrille Amar, Grégoire Goussu and Antonin Staub are also strong advisers.

Armengaud Guerlain brings ‘high quality work’ in patents and trade marks. The firm handles high-level cases, including cross-border matters, in various fields such as electronics and pharmaceuticals. Virbac, Andros, L’Oréal and Bouygues are clients. The practice is led by Stéphane Guerlain and Catherine Mateu, who ‘puts her clients’ interests first’.

The ‘very proactive, flexible and cost-efficient’ team at August Debouzy produces ‘creative solutions; there is always a solution’. The 11-lawyer team represents many leading companies in pan-European litigation and is especially strong in the healthcare sector. It successfully acted for Teva in challenging the validity of Merck’s patent on hair loss treatment finasteride. The firm is also representing Orange in a high-profile patent enforcement case against Free. The team is led by François Pochart and Grégoire Desrousseaux; ‘being both an engineer and a lawyer, he has a quick understanding of the issues and has a synthetic approach’.

DLA Piper is involved in several strategic patent cases relating to medical devices. Recent successes include representing Advanced Biological Laboratories in a patent dispute with Onxeo regarding therapeutic treatment processes, as well as acting for Andritz AG in a patent and trade mark infringement case with Tessier regarding clips for the production of degradable and antibacterial films. Medtronic and West Pharmaceutical Services are also clients. Practice head Jean-Christophe Tristant is strongly recommended.

Dechert LLP ranks among ‘the strongest firms in France in patent litigation’. The team is involved in some of the most challenging and ground-breaking cases in the electronics sector and is also handling key matters in the healthcare and other areas. Lisi Aerospace, Pierre Fabre, LG Electronics, Saint Gobain and Tate & Lyle are clients. Practice head Marianne Schaffner is ‘very experienced and an excellent team leader’. The practice hired Marie Fillon from DTMV & Associés, following the departure of Romain Viret to Reed Smith.

Hogan Lovells (Paris) LLP is handling top patent litigation cases in the healthcare sector, including a number of multi-jurisdictional cases. The practice has been representing Icos in proceedings relating to validity claims against two of its urology patents on Cialis. The firm is also managing cases in other areas, including assisting HTC in a dispute with Philips regarding handset display and motion sensing patent technologies. Eli Lilly is another client. Stanislas Roux-Vaillard is the key figure.

Jones Day’s ‘very solid and professional’ team has ‘great IP knowledge and experience’ and provides ‘concrete advice’. The firm deals with a wide range of patent litigation, but especially in healthcare and IT, internet and smart objects. It is representing Merck & Co in a dispute with Gilead Sciences involving Solvadi, a hepatitis C drug. Daiichi Sankyo and ERDF are also clients. Practice head Emmanuel Baud shows ‘complete mastery of his field’. Thomas Bouvet joined with a four-lawyer team from Véron & Associés, a move that is viewed as highly promising for the future of the practice.

The ‘excellent’ team at Loyer & Abello is ‘extremely responsive, commercially aware and highly skilled’. Patent work covers various sectors, including energy, mechanical engineering, telecoms and pharmaceuticals. The team recently represented Viiv Healthcare in patent litigation with Teva and Mylan, as well as successfully acting for Manitou in litigation with Haulotte which resulted in a large damages award to the client. Practice head Michel Abello is ‘competent in various fields and has good analytical skills’.

Reed Smith shows ‘great business acumen’ in the healthcare sector, where the team has ‘in-depth responses and also goes the extra mile to understand the industry’. The firm is involved in a number of multi-jurisdictional patent infringement actions. Recent cases include representing Novozymes in a dispute with DSM. Roquette Frères is also a client. The five-lawyer team also handles mechanical matters. Practice co-heads Marina Cousté and François Jonquères are ‘excellent and very knowledgeable professionals who are sensitive to the manner in which to present a case’. Of counsel Romain Viret recently joined from Dechert LLP.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

GC Powerlist -

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in France

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • The new French regulation applying to national insurance contributions for managers and shareholders

    French insurance contributions on executive and shareholder remuneration (pay + dividends) have been substantially increased by the National Insurance Funding for 2013 Act, No. 2012-1404, of 17th December 2012. Until 31st December 2012, all dividends were subject to national insurance contributions on unearned income but henceforth, under Article L136-3 of the National Insurance Code, amended by Act No. 2012-1404, certain dividends   are considered as pay received by executives and shareholders and are therefore subject to the national insurance contributions on pay. The Act also abolished the ceiling on health insurance contributions payable by the self-employed and all this means that businesses must rethink the way that they have been structured until now.

    The People's Republic of China has initiated an overhaul of its social security system, reformed the personal taxation regime and has extended the scope of these laws to foreigners residing in China.

    The Kingdom of Morocco is supporting the ambition of becoming the leading financial place for Africa. In this context, a wave of draft laws is to be passed and implemented within the following months, amongst which, the Law No. 53.08, setting up a new financial authority, and the Law No. 54.08, reforming public offering rules, are of paramount importance to Moroccan and foreign issuers, and financial institutions.

    The opportunities offered to foreign investors by the Chinese mergers and acquisitions market are increasing every year: in 2010, transactions involving foreign companies came to 60.1 billion euros, an increase of 21.2% compared with 2009. Seen from the West, where markets are declining, all sectors of the Chinese economy seem to be undergoing promising development and the statistics indicate that the Middle Empire will be a lasting springboard for growth.
  • Prime de Partage des Profits

    Le dispositif L’article 1er de la loi de financement rectificative de la Sécurité sociale pour 2011 oblige les sociétés commerciales de 50 salariés et plus, dont les dividendes par part sociale ou par action sont en augmentation par rapport à la moyenne des deux années précédentes, à verser une prime à l’ensemble de leurs salariés

    Types of investors The private equity (PE) funds that are active in Bulgaria are not raised or registered in the country. Some Bulgarian PE funds were raised recently, but there are no statistics as to the sources of their funding, their number, the funds that were accumulated, etc.

  • Landmark decision by French Competition Authority in conditioned LPG case

    cartel case closed after discovery that leniency application was largely based on forgeries and rejection of collective dominant position objection.
  • 2012 supplementary budget

    The second supplementary budget published in the Official Gazette September 19, 2011 provides for two key measures that affect the deferral of tax losses and taxation of capital gains realized on the sale of equity securities .
  • Actualité législative fiscale

    Au delà des mesures applicables à l’ensemble des contribuables (telles que la limitation du report des déficits ou la réforme du mode de calcul des plus values sur cessions de participations),le plan de réduction des déficits annoncé le 24 août dernier par le gouvernement comprend des mesures qui intéressent spécifiquement les acteurs du secteur financier.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to